- Home
- TEF vs BNTX Comparison
TEF vs BNTX Comparison
Compare TEF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEF | BNTX |
|---|---|---|
| Founded | 1924 | 2008 |
| Country | Spain | Germany |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3B | 24.8B |
| IPO Year | 1987 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TEF | BNTX |
|---|---|---|
| Price | $4.04 | $94.95 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $137.40 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | ★ 6.18% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,832,570,697.00 | $3,698,814,972.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $0.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.59 | ★ 3.70 |
| 52 Week Low | $3.89 | $81.20 |
| 52 Week High | $5.72 | $129.27 |
Technical Indicators
Market Signals| Indicator | TEF | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.48 | 45.84 |
| Support Level | $3.95 | $94.00 |
| Resistance Level | $4.10 | $95.71 |
| Average True Range (ATR) | 0.06 | 1.74 |
| MACD | 0.01 | 0.52 |
| Stochastic Oscillator | 34.44 | 62.66 |
Price Performance
Historical ComparisonAbout TEF Telefonica SA
Telefonica is a telecom operator with presence in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.